Detailed phosphoproteomic analysis from cell lines and patient tumors also revealed involvement of RTKs such as PDGFR, Eph receptors, Axl, c-Met and IGF1-R [9] as potential driver kinases in sarcomas. This evidence concerns the gene IGF1R and sarcoma.